Form S-1 Invea Therapeutics, Inc
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
Invea Therapeutics (INAI) files for proposed IPO
December 15, 2025 6:19 AM EST(Updated - December 15, 2025 6:20 AM EST)
Invea Therapeutics (INAI) has filed for a proposed Nasdaq IPO.
The company describes itself as: "We are a biotechnology company seeking to develop oral, small-molecule therapies for immune-mediated inflammatory diseases, or IMIDs. IMIDs are a diverse group of conditions including skin or cutaneous... More



